Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor

Published 2017 View Full Article

Authors

Keywords

IDO1, Aryl Hydrocarbon Receptor, IDO inhibitors, AHR agonists, Cancer, Clinical trials

Journal

TOXICOLOGY AND APPLIED PHARMACOLOGY

Volume 323, Issue -, Pages 74-80

Publisher

Elsevier BV

Online

2017-03-21

DOI

10.1016/j.taap.2017.03.012

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now